Hims & Hers Expands Platform-Led Access to Provider-Directed Care

Core Insights - Hims & Hers Health, Inc. operates as an intermediary healthcare platform, connecting consumers with independent licensed healthcare providers, without practicing medicine itself [1][2][3] Business Model - The company facilitates interactions through its digital platform, allowing customers to submit health information, connect with providers, manage prescriptions, and engage continuously, while maintaining a separation between platform operations and medical judgment [1][2] - Hims & Hers has expanded into new provider-led categories such as low testosterone care and menopause support, utilizing licensed third-party clinicians to deliver these services [2][7] Market Position and Growth - By aggregating providers, diagnostics, pharmacies, and manufacturers, Hims & Hers scales access to personalized healthcare, supporting both domestic growth and international expansion [3] - The company's shares have increased by 22.4% over the past year, outperforming the industry average growth of 4.3% [6] Financial Estimates - The Zacks Consensus Estimate for Hims & Hers' 2025 earnings per share indicates a significant improvement of 77.8% compared to 2024 [8] - The forward 12-month price-to-sales ratio for Hims & Hers is 2.60X, which is lower than the industry average of 4.82X and its three-year median of 2.64X [10] Earnings Projections - Current quarter earnings per share estimate stands at 0.04, with next quarter at 0.14, and the current year estimate at 0.48, showing a year-over-year growth of -63.64% for the current quarter but a projected growth of 77.78% for the next year [11]